Respiratory syncytial virus (RSV): FDA approves first vaccine for respiratory syncytial virus

Source: The post is based on the article “FDA approves first vaccine for respiratory syncytial virus” published in The Hindu on 6th May 2023 What is the News? The Food and Drug Administration (FDA) has approved the first vaccine — Arexvy — for respiratory syncytial virus (RSV) to lower respiratory tract disease in people older… Continue reading Respiratory syncytial virus (RSV): FDA approves first vaccine for respiratory syncytial virus

Blog
Academy
Community